inositol has been researched along with triazoles in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.26) | 18.7374 |
1990's | 4 (21.05) | 18.2507 |
2000's | 2 (10.53) | 29.6817 |
2010's | 12 (63.16) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, A; Smith, SK | 1 |
Franklin, R; Gelfand, EW; Mazer, BD; Sawami, H | 1 |
Fatiadi, AJ | 1 |
Ahmed, A; Plevin, R; Sage, SO; Sharkey, AM; Shoaibi, MA; Smith, SK | 1 |
Adler, KB; Dodam, JR; Olson, NC | 1 |
Lou, H; Zhan, T | 1 |
Handa, T; Matsunaga, H; Terakita, A | 1 |
Amatruda, JM; Arjona Ferreira, JC; Iwamoto, Y; Kadowaki, T; Nishii, M; Nonaka, K; Tajima, N; Taniguchi, T | 1 |
Castanheira, M; Diekema, DJ; Duncanson, FP; Guarro, J; Jones, RN; Pfaller, MA | 1 |
Ayaori, M; Iizuka, M; Ikewaki, K; Iwakami, N; Komatsu, T; Murakami, T; Nakaya, K; Ogura, M; Sasaki, M; Sato, H; Takase, B; Takiguchi, S; Uto-Kondo, H; Yakushiji, E; Yogo, M | 1 |
Ando, K; Morimoto, A; Nishimura, R; Sakamoto, M; Seo, C; Tsujino, D; Utsunomiya, K | 1 |
Kawata, T; Matsubara, F; Nagai, Y; Nakamura, Y; Ohshige, T; Ohta, A; Sakai, K; Tanaka, Y; Tenjin, A; Terashima, Y; Tsukiyama, S | 1 |
Hanaoka, H; Hashimoto, N; Ishikawa, K; Kanatsuka, A; Kobayashi, K; Kuribayashi, N; Onishi, S; Sakurai, K; Sato, Y; Takemoto, M; Terano, T; Uchida, D; Yokoh, H; Yokote, K | 1 |
Ishida, H; Osonoi, T; Osonoi, Y; Saito, M; Tamasawa, A | 1 |
Fukuda, S; Hirata, K; Ito, H; Kihara, H; Miyoshi, T; Nakamura, K; Oe, H; Shimada, K; Takagi, T; Watanabe, K; Yoshikawa, J; Yunoki, K | 1 |
Cheng, J; Fang, JC; Ge, LQ; Li, X; Lu, XL; Wu, JC; Zhu, ZF | 1 |
Garvey, L; Rojas, JH; Taylor-Robinson, S; Vigneswaran, S; Winston, A | 1 |
Cao, L; Huang, Q; Liu, Y; Wu, Y; Zhang, J; Zhao, C | 1 |
Legro, RS | 1 |
1 review(s) available for inositol and triazoles
Article | Year |
---|---|
Ovulation induction in polycystic ovary syndrome: Current options.
Topics: Anovulation; Anti-Obesity Agents; Aromatase Inhibitors; Bariatric Surgery; Clomiphene; Diet Therapy; Exercise Therapy; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypoglycemic Agents; Infertility, Female; Inositol; Insulin Resistance; Letrozole; Metformin; Nitriles; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Selective Estrogen Receptor Modulators; Triazoles | 2016 |
6 trial(s) available for inositol and triazoles
Article | Year |
---|---|
Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial.
Topics: Asian People; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inositol; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2010 |
Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Cholesterol, LDL; Cross-Over Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inositol; Japan; Linear Models; Male; Middle Aged; Piperidines; Prospective Studies; Pyrazines; Regional Blood Flow; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles; Uracil; Vasodilation | 2013 |
Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naïve Japanese patients with type 2 diabetes.
Topics: Aged; Asian People; Blood Glucose; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Inositol; Insulin; Isoindoles; Male; Middle Aged; Pyrazines; Serum Albumin; Sitagliptin Phosphate; Triazoles | 2013 |
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with α-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS-2): a multicenter, randomized, open-label, non-i
Topics: 1-Deoxynojirimycin; Aged; alpha-Glucosidases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Gastrointestinal Agents; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Inositol; Japan; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Triazoles | 2014 |
Effects of sitagliptin or mitiglinide as an add-on to acarbose on daily blood glucose fluctuations measured by 72 h subcutaneous continuous glucose monitoring in Japanese patients with type 2 diabetes: a prospective randomized study.
Topics: Acarbose; Aged; Asian People; Blood Glucose; Diabetes Mellitus, Type 2; Drug Substitution; Drug Therapy, Combination; Female; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Isoindoles; Male; Middle Aged; Prospective Studies; Pyrazines; Serum Albumin; Sitagliptin Phosphate; Triazoles | 2014 |
DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Endothelium, Vascular; Female; Glycoside Hydrolase Inhibitors; Humans; Inositol; Male; Middle Aged; Prospective Studies; Pyrazines; Sitagliptin Phosphate; Triazoles; Young Adult | 2014 |
12 other study(ies) available for inositol and triazoles
Article | Year |
---|---|
Platelet-activating factor stimulates phospholipase C activity in human endometrium.
Topics: Adult; Azepines; Cells, Cultured; Chromatography, Ion Exchange; Dose-Response Relationship, Drug; Endometrium; Female; Humans; Inositol; Inositol Phosphates; Middle Aged; Platelet Activating Factor; Time Factors; Triazoles; Type C Phospholipases | 1992 |
B-cell activation and regulation of immunoglobulin synthesis by platelet activating factor.
Topics: Azepines; B-Lymphocytes; Calcium; Cell Differentiation; Cell Line; Inositol; Lymphocyte Activation; Phospholipid Ethers; Platelet Activating Factor; Receptors, Antigen, B-Cell; Triazoles | 1991 |
(p-Bromophenyl)osotriazoles from inositols.
Topics: Carbohydrates; Crystallization; Cyclohexanes; Hydrazones; Inositol; Ketones; Magnetic Resonance Spectroscopy; Triazoles | 1971 |
Functional platelet-activating factor receptors linked to inositol lipid hydrolysis, calcium mobilization and tyrosine kinase activity in the human endometrial HEC-1B cell line.
Topics: Azepines; Calcium; Cell Line; Endometrium; Female; Fura-2; Humans; Hydrolysis; Inositol; Inositol 1,4,5-Trisphosphate; Lipid Metabolism; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles | 1994 |
Effect of pertussis toxin and B-oligomer on platelet-activating factor-induced generation of inositol phosphates in porcine alveolar macrophages.
Topics: Adenosine Diphosphate Ribose; Aluminum Chloride; Aluminum Compounds; Analysis of Variance; Animals; Azepines; Bronchoalveolar Lavage; Cell Survival; Cells, Cultured; Chlorides; GTP-Binding Proteins; Inositol; Inositol Phosphates; L-Lactate Dehydrogenase; Macrophages, Alveolar; NAD; Pertussis Toxin; Platelet Activating Factor; Platelet Aggregation Inhibitors; Random Allocation; Sodium Fluoride; Swine; Triazoles; Type C Phospholipases; Virulence Factors, Bordetella | 1996 |
Synthesis of azole nucleoside analogues of D-pinitol as potential antitumor agents.
Topics: Antineoplastic Agents; Azoles; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Humans; Inositol; Molecular Structure; Nucleosides; Triazoles | 2007 |
The influence of water on the stability of lyophilized formulations with inositol and mannitol as excipients.
Topics: Chromatography, High Pressure Liquid; Drug Stability; Excipients; Freeze Drying; Imidazoles; Inositol; Magnetic Resonance Spectroscopy; Mannitol; Molecular Structure; Phase Transition; Tetrazoles; Triazoles; Water | 2009 |
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
Topics: Acylation; Aminopyridines; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Fusarium; Glycosylphosphatidylinositols; Humans; Inositol; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2012 |
Comparison of glycemic variability in patients with type 2 diabetes given sitagliptin or voglibose: a continuous glucose monitoring-based pilot study.
Topics: Aged; Asian People; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Drug Combinations; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Japan; Male; Middle Aged; Monitoring, Physiologic; Pilot Projects; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles | 2013 |
Comparisons of topical and spray applications of two pesticides, triazophos and jinggangmycin, on the protein content in the ovaries and fat bodies of the brown planthopper Nilaparvata lugens Stål (Hemiptera:Delphacidae).
Topics: Animals; Fat Body; Female; Fungicides, Industrial; Hemiptera; Inositol; Insect Proteins; Insecticides; Organothiophosphates; Ovary; Triazoles | 2014 |
Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.
Topics: Adult; Antiretroviral Therapy, Highly Active; Aspartic Acid; Basal Ganglia; Brain; Brain Chemistry; Cohort Studies; Creatine; Cyclohexanes; Female; Hepatitis C; HIV Fusion Inhibitors; HIV Infections; Humans; Inositol; Magnetic Resonance Imaging; Male; Maraviroc; Middle Aged; Proton Magnetic Resonance Spectroscopy; Protons; Triazoles; Young Adult | 2015 |
Enhanced Germicidal Efficacy by Co-Delivery of Validamycin and Hexaconazole with Methoxy Poly(ethylene glycol)-Poly(lactide-co-glycolide) Nanoparticles.
Topics: Antifungal Agents; Delayed-Action Preparations; Inositol; Nanoparticles; Polyesters; Polyethylene Glycols; Rhizoctonia; Triazoles | 2016 |